It is both an honor and a challenge to summarize this year’s Aspen Lung Conference, organized by York Miller and Bob Keith, with the capable assistance of Jeanne Cleary. They have managed to attract an outstanding variety of leading investigators from around the world working on all of the major aspects of this topic, and no summary can do justice to the wealth of information presented or the quality of the scientific interactions that took place.
It is a particular pleasure for me to both attend and summarize this particular conference, as it is organized and run by pulmonologists, and I am a medical oncologist. The fact that this conference focuses on lung cancer signifies an era of increasing awareness and collaboration between pulmonary medicine and the oncology specialties that is desperately important if we are to make real progress in fighting this disease. This has not always been the case.